Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers

Keyphrases

• Cancer Information 17%
• CARMENA 5%
• Chemotherapy 5%
• Confidence Interval 11%
• Confounding Variables 5%
• Cox Proportional Hazards Model 5%
• Cytoreductive Nephrectomy 100%
• Hazard Ratio 11%
• Histology 5%
• Initial Treatment 5%
• Intermediate Risk 5%
• International Metastatic Renal Cell Carcinoma Database Consortium 5%
• Inverse Probability of Treatment Weighting 5%
• Kidney Cancer 17%
• Measurement Analysis 5%
• Metastatic Renal Cell Carcinoma (mRCC) 100%
• Optimal Treatment 5%
• Patient Selection 5%
• Propensity Score 5%
• Statistical Analysis 5%
• Surgery Therapy 11%
• SURTIME 5%
• Survival Benefit 5%
• Synchronous Diseases 5%
• System Database 5%
• Systemic Therapy 100%
• Treatment Group 5%
• Treatment Options 11%
• Treatment Sequence 5%
• Weight Analysis 5%

Medicine and Dentistry

• Cohort Analysis 5%
• Disease 5%
• Group Therapy 5%
• Hazard Ratio 11%
• Immunotherapy 5%
• Kidney Cancer 17%
• Kidney Metastasis 100%
• Metastatic Kidney Cancer 5%
• Nephrectomy 100%
• Outcome Assessment 5%
• Proportional Hazards Model 5%
• Systemic Therapy 100%